COO Aktienübersicht
The Cooper Companies, Inc. entwickelt, produziert und vermarktet zusammen mit ihren Tochtergesellschaften Kontaktlinsenträger. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 0/6 |
Belohnungen
Risikoanalyse
COO unsere Risikoprüfungen bestanden.
The Cooper Companies, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$99.63 |
| 52-Wochen-Hoch | US$112.38 |
| 52-Wochen-Tief | US$82.22 |
| Beta | 0.99 |
| 11 Monat Veränderung | -8.23% |
| 3 Monate Veränderung | 5.83% |
| 1 Jahr Veränderung | 18.21% |
| 33 Jahre Veränderung | -1.62% |
| 5 Jahre Veränderung | 29.47% |
| Veränderung seit IPO | 1,191.69% |
Aktuelle Nachrichten und Updates
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01
Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15Recent updates
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Aktionärsrenditen
| COO | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | -4.0% | -1.1% | -2.2% |
| 1Y | 18.2% | 23.0% | 30.1% |
Rendite im Vergleich zur Industrie: COO unter dem Niveau der Branche US Medical Equipment , die im vergangenen Jahr eine Rendite von 23% erzielte.
Rendite vs. Markt: COO hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 30.1 erzielte.
Preisvolatilität
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: COO hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.
Volatilität im Zeitverlauf: COODie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc. entwickelt, produziert und vertreibt zusammen mit ihren Tochtergesellschaften Kontaktlinsen. Das Unternehmen ist in zwei Segmenten tätig, CooperVision und CooperSurgical. Das Segment CooperVision bietet sphärische Linsen, einschließlich Linsen, die Kurz- und Weitsichtigkeit korrigieren, sowie torische und multifokale Linsen, die Linsen zur Korrektur von Sehschwächen wie Astigmatismus, Alterssichtigkeit und Kurzsichtigkeit in Nord- und Südamerika, Europa, dem Nahen Osten, Afrika und dem Asien-Pazifik-Raum umfassen.
The Cooper Companies, Inc.'s Grundlagenzusammenfassung
| COO grundlegende Statistiken | |
|---|---|
| Marktanteil | US$19.89b |
| Gewinn(TTM) | US$359.30m |
| Umsatz(TTM) | US$3.80b |
55.2x
Kurs-Gewinn-Verhältnis5.2x
Kurs-Umsatz-VerhältnisIst COO zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| COO Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$3.80b |
| Kosten der Einnahmen | US$1.28b |
| Bruttogewinn | US$2.52b |
| Sonstige Ausgaben | US$2.17b |
| Umsatz | US$359.30m |
Zuletzt gemeldete Gewinne
Jul 31, 2024
Datum des nächsten Gewinnberichts
Dec 05, 2024
| Gewinn per Aktie (EPS) | 1.80 |
| Bruttomarge | 66.36% |
| Nettogewinnspanne | 9.45% |
| Schulden/Eigenkapital-Verhältnis | 33.2% |
Wie hat sich COO auf lange Sicht entwickelt?
Historische Performance und Vergleiche